外周血单个核细胞在脓毒症期间显示线粒体损伤清除
这项前瞻性病例对照研究在学术医学中心和退伍军人医院纳入20例未感染对照和37例脓毒症ICU患者,对照单次采血,脓毒症患者于第1、3、5天系列采血并记录临床数据,用定量逆转录聚合酶链反应检测HMOX1、NRF1、PPARGC1A、TFAM基因产物及线粒体DNA ND1和D-loop,并测血浆和中性粒细胞裂解物中的促炎细胞因子。结果示脓毒症患者第1天四个基因转录水平均显著降低(p<0.05),线粒体DNA拷贝数下降、血浆D-loop升高(均p<0.05),提示线粒体损伤;D-loop含量与肿瘤坏死因子-α和高迁移率族蛋白B1细胞因子表达成正比。至第5天观察到线粒体生物合成转录激活和线粒体DNA拷贝数恢复(p<0.05),早期激活线粒体生物合成的患者1周内脱离ICU。作者认为外周血单个核细胞中无创检测的基因转录本可作为脓毒症恢复的新型生物标志物。
要点
- 脓毒症患者第1天外周血单个核细胞HMOX1、NRF1、PPARGC1A、TFAM四个基因转录水平均显著降低(p<0.05)。
- 第1天线粒体DNA拷贝数下降、血浆D-loop升高(均p<0.05),提示线粒体损伤。
- D-loop含量与肿瘤坏死因子-α和高迁移率族蛋白B1细胞因子表达成正比。
- 至第5天线粒体生物合成转录激活、线粒体DNA拷贝数恢复(p<0.05)。
- 早期激活线粒体生物合成的患者1周内脱离ICU。
适用人群与场景
- 未感染对照患者(n=20)与脓毒症ICU患者(n=37),来自学术医学中心和退伍军人医院。
- 脓毒症患者于第1、3、5天系列采血并采集临床数据,对照患者仅单次采血。
诊断标准与关键阈值
- 脓毒症患者入ICU时急性生理与慢性健康评估II中位数(四分位距)为21(8),序贯器官衰竭评估为10(4)。
研究设计与关键结果
- 前瞻性病例对照研究,纳入未感染对照患者n=20和脓毒症ICU患者n=37,90天死亡率为19%。
- 脓毒症患者第1天外周血单个核细胞HMOX1、NRF1、PPARGC1A、TFAM四个基因转录水平均显著降低(p<0.05),同时线粒体DNA拷贝数下降、血浆D-loop升高(均p<0.05),提示线粒体损伤。
- D-loop含量与肿瘤坏死因子-α和高迁移率族蛋白B1细胞因子表达成正比。
- 至第5天观察到线粒体生物合成转录激活和线粒体DNA拷贝数恢复(p<0.05)。
- 早期激活线粒体生物合成的患者1周内脱离ICU。
证据类型、等级与局限
- 证据类型:前瞻性病例对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为脓毒症诱导的线粒体损伤可通过激活线粒体生物合成而逆转,外周血单个核细胞中无创检测的基因转录本可作为脓毒症恢复的新型生物标志物。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Metabolic derangements in sepsis stem from mitochondrial injury and contribute significantly to organ failure and mortality; however, little is known about mitochondrial recovery in human sepsis. We sought to test markers of mitochondrial injury and recovery (mitochondrial biogenesis) noninvasively in peripheral blood mononuclear cells from patients with sepsis and correlate serial measurements with clinical outcomes.
DESIGN: Prospective case-control study.
SETTING: Academic Medical Center and Veterans Affairs Hospital.
PATIENTS: Uninfected control patients (n = 20) and septic ICU patients (n = 37).
INTERVENTIONS: Blood samples were collected once from control patients and serially with clinical data on days 1, 3, and 5 from septic patients. Gene products for HMOX1, NRF1, PPARGC1A, and TFAM, and mitochondrial DNA ND1 and D-loop were measured by quantitative reverse transcriptase-polymerase chain reaction. Proinflammatory cytokines were measured in plasma and neutrophil lysates.
MEASUREMENTS AND MAIN RESULTS: Median (interquartile range) Acute Physiology and Chronic Health Evaluation II and Sequential Organ Failure Assessment scores were 21 (8) and 10 (4), respectively, and 90-day mortality was 19%. Transcript levels of all four genes in peripheral blood mononuclear cells were significantly reduced in septic patients on day 1 (p < 0.05), whereas mitochondrial DNA copy number fell and plasma D-loop increased (both p < 0.05), indicative of mitochondrial damage. D-loop content was directly proportional to tumor necrosis factor-α and high-mobility group protein B1 cytokine expression. By day 5, we observed transcriptional activation of mitochondrial biogenesis and restoration of mitochondrial DNA copy number (p < 0.05). Patients with early activation of mitochondrial biogenesis were ICU-free by 1 week.
CONCLUSIONS: Our findings support data that sepsis-induced mitochondrial damage is reversed by activation of mitochondrial biogenesis and that gene transcripts measured noninvasively in peripheral blood mononuclear cells can serve as novel biomarkers of sepsis recovery.
参考来源
- Kraft BD, Chen L, Suliman HB, et al. Peripheral Blood Mononuclear Cells Demonstrate Mitochondrial Damage Clearance During Sepsis. Crit Care Med. 2019. PMID: 30730439. doi:10.1097/CCM.0000000000003681
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。